Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
A dried preparation of liposomes containing muramyl tripeptide phosphatidylethanolamine as a potent activator of human blood monocytes to the antitumor stateSONO, S ; UTSUGI, T ; TANDON, P ; OGAWARA, MCancer Immunology Immunotherapy, 1986-07, Vol.22 (3), p.191-196 [Peer Reviewed Journal]Berlin: SpringerFull text available |
|
2 |
Material Type: Article
|
Systemic activation of tumoricidal properties in mouse macrophages and inhibition of melanoma metastases by the oral administration of MTP-PE, a lipophilic muramyl dipeptideFidler, IJ ; Fogler, WE ; Brownbill, AF ; Schumann, GThe Journal of immunology (1950), 1987-06, Vol.138 (12), p.4509-4514 [Peer Reviewed Journal]Bethesda, MD: Am Assoc ImmnolFull text available |
|
3 |
Material Type: Article
|
The lipophilic muramyl peptide MTP-PE is a potent inhibitor of HIV replication in macrophagesLAZDINS, J. K ; WOODS-COOK, K ; WALKER, M ; ALTERI, EAIDS research and human retroviruses, 1990-10, Vol.6 (10), p.1157-1161 [Peer Reviewed Journal]Larchmont, NY: LiebertFull text available |
|
4 |
Material Type: Article
|
Comparative efficacy of liposomes containing synthetic bacterial cell wall analogues for tumoricidal activation of monocytes and macrophagesUTSUGI, T ; NII, A ; FAN, D ; PAK, D ; DENKINS, C. C ; VAN HOOGEVEST, P ; FIDLER, I. JCancer Immunology, Immunotherapy, 1991-09, Vol.33 (5), p.285-292 [Peer Reviewed Journal]Berlin: SpringerFull text available |
|
5 |
Material Type: Article
|
DECREASED SERUM LEVEL OF TUMOR-NECROSIS-FACTOR IN ANIMALS TREATED WITH LIPOPOLYSACCHARIDE AND LIPOSOMES CONTAINING PHOSPHATIDYLSERINEMONASTRA, G ; BRUNI, ALymphokine and cytokine research, 1992-02, Vol.11 (1), p.39-43LARCHMONT: MARY ANN LIEBERT INC PUBLNo full-text |
|
6 |
Material Type: Article
|
Protection against lethal pneumococcal septicemia in pigs is associated with decreased levels of interleukin-6 in bloodZIEGLERHEITBROCK, HWL ; PASSLICK, B ; KAFFERLEIN, E ; COULIE, PG ; IZBICKIInfection and Immunity, 1992-04, Vol.60 (4), p.1692-1694 [Peer Reviewed Journal]WASHINGTON: American Society for MicrobiologyFull text available |
|
7 |
Material Type: Article
|
The schistosomulicidal activity and the production of IL‐1 and TNF‐α by peritoneal macrophages from infected mice and their potentiation by muramyl tripeptide‐phosphatidyl ethanolamine (MTP‐PE) treatmentSEGER, M. ; GOLD, D. ; LENGY, J. ; PAULI, H. ; KEISARI, Y.Parasite immunology, 1993-06, Vol.15 (6), p.339-347 [Peer Reviewed Journal]Oxford, UK: Blackwell Publishing LtdNo full-text |
|
8 |
Material Type: Article
|
Anti-(tumor necrosis factor) alters the response of human monocytes to liposomal muramyl tripeptideMAEDA, M ; ASANO, T ; KLEINERMAN, E. SCancer Immunology Immunotherapy, 1993-08, Vol.37 (3), p.203-208 [Peer Reviewed Journal]Berlin: SpringerFull text available |
|
9 |
Material Type: Article
|
Effect of Adriamycin on liposomal muramyl tripeptide's ability to up-regulate monocyte cytokine expressionAsano, T ; Fujimaki, W ; McWatters, A ; An, T ; Matsushima, K ; Kleinerman, E SCancer Immunology Immunotherapy, 1993-11, Vol.37 (6), p.408-411 [Peer Reviewed Journal]Germany: Springer-VerlagFull text available |
|
10 |
Material Type: Article
|
Liposome-encapsulated MTP-PE : a novel biologic agent of cancer therapyASANO, T ; KLEINERMAN, E. SJournal of immunotherapy, 1993-11, Vol.14 (4), p.286-292 [Peer Reviewed Journal]New York, NY: Raven PressNo full-text |